Biological sample procurement company iSpecimen plans to establish a $200 million digital asset reserve and purchase SOL through OTC transactions.
ChainCatcher news, according to Investing, biospecimen procurement company iSpecimen Inc. (ISPC) announced that several cryptocurrency companies have approached it to offer investment opportunities. The company is planning to establish a digital asset portfolio valued at $200 million, aiming to diversify its balance sheet and support its growth plans through tokenized real-world assets and top-ranked cryptocurrencies.
iSpecimen is continuing parallel discussions to develop a financial plan based on the Solana blockchain. The company plans to purchase SOL through over-the-counter transactions with cryptocurrency institutions, including locked SOL with contract transfer or vesting restrictions.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Glassnode: Short-term holders bore most of the losses during this BTC correction
Matrixport: Bitcoin's current rebound is more reflected in position structure rather than price itself
Ethereum Prysm client bug causes validator participation to drop by 25%, nearly resulting in loss of finality
Trending news
MoreCrypto prices
More
